Esteve Healthcare’s Acquisition of Pharma Rare Diseases Business From Perrigo

Wachtell, Lipton, Rosen & Katz advised Perrigo, while Clifford Chance advised ESTEVE on the deal.Perrigo Company plc (NYSE: PRGO) announced that pharmaceutical company Esteve Healthcare, S.L….

This content is for Standard 1 Year members only.
Login Join Now

Gilgamesh Pharmaceuticals’ Collaboration with AbbVie

Avathon Capital’s Acquisition of Summit Professional Education

Danti’s $5 Million Seed Financing Round

Raghsa’s US$10 Million Notes Issuance

San Miguel’s Public Offering

Cresud’s US$10 Million Notes Offering

Abound’s Additional £800 Million Funding Round

Kindred Nurseries’ Acquisition Of Whitton Day Nursery

Wille Finance’s Acquisition Of SwissComply

JS Virginia Proprietary Ltd’s Financing Of Renewable Project In South Africa

Injaro Investment Advisors’ Equity Investment in NME

Dislog Group’s Acquisition of CMB Plastique Maroc

OSN’s Acquisition of a Control Stake in Anghami

McLaren’s Successful Reorganisation with Mumtalakat

Skyports Infrastructure’s Dubai Launch

Marketingforce Management’s IPO on the Hong Kong Stock Exchange

Salmon’s $25 Million Series A-1 Financing

National Highways Authority of India’s Institutional Placement

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

BCLP Makes New Leadership Appointments

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

Katten Taps James Bookhout to Lead M&A Litigation in Dallas

Hinshaw Expands Health Care Practice on East Coast

Intellectual Property Partner Jeff Morton Joins Haynes Boone in Southern California

Esteve Healthcare’s Acquisition of Pharma Rare Diseases Business From Perrigo

Author: Laura Testa